Sign in →

Test Code CEA-O CEA, Body Fluid

Useful For

Aids in distinguishing between mucinous and non-mucinous pancreatic cysts and likelihood of a malignant pancreatic cyst when used in conjunction with imaging studies cytology and other pancreatic cyst tumor markers.

 

An adjuvant to cytology and imaging studies to differentiate between nonmalignant and malignant causes of pleural effusions & peritoneal fluid.

Synonyms/Keywords

Body Fluid CEA, Carcinoembryonic Ag-Other

Specimen Requirements

Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
Pancreatic Cyst Fluid / Body Fluid Body Fluid Container Plastic Vial 300 uL 100 uL N/A

Collection/Processing Instructions

Do not collect the specimen with preservatives or anticoagulants.

 

Specimens should be centrifuged to remove cells or clots, if present.

Specimen Stability Information

Specimen Type Temperature Time
Pancreatic Cyst Fluid / Body Fluid Ambient N/A
Refrigerated 7 days
Frozen at -20 deg Celsius 30 days
Frozen at -70 deg Celsius > 30 Days
One freeze and thaw cycle acceptable

Rejection Criteria

Blood or Urine

Interferences

The possibility exists for interference by heterophile antibodies & HAMA in the patient sample regularly exposed to animals or has received immunotherapy or diagnostic procedures utilizing immunoglobulins or immunoglobulin fragments.

Interpretations

Diagnosis of a pancreatic cyst is often difficult and requires correlation of imaging studies, cytology studies and tumor marker results on cyst aspirates. Carcinoembryonic antigen (CEA) has been found to be most helpful tumor marker in differentiating between mucinous and non-mucinous pancreatic cysts. Higher concentrations of CEA have greater likelihood that mucinous cyst may be malignant but CEA does not distinguish between benign, premalignant or malignant mucinous cysts.
 

Based on evidence available and recommendations by the American College of Gastroenterology (ACG) practice guidelines for the Diagnosis and Management of Neoplastic Pancreatic Cysts (Am. J. Gastroenterol. 2007; 102: 2339-2349), a pancreatic cyst fluid CEA concentration > 800 ng/ml has high specificity to exclude pseudocysts and concentration > 200 ng/mL is suggestive but not diagnostic of mucinous cyst. Cyst fluid concentrations of ≤ 5 ng/ml indicate low risk for mucinous cyst and are more consistent of serous cystadenoma.
 

This test does not distinguish between malignant and non-malignant mucinous cysts. Test should not be ordered for pancreatic fluid of non-cyst origin.

Reference Range Information

Performing Location Reference Range
Marshfield Reference cut-off limits for CEA for pancreatic cyst fluid and other body fluids have not been established and verified.

The test results should not be the sole basis of diagnosis and always be correlated with imaging and cytology.

Marshfield Labs Performing Department

Marshfield Labs Chemistry

Performing Information

Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
Marshfield Monday through Sunday Less than 2 hours  Two-step Sandwich Immunoassay using Direct Chemiluminometric Technology/Siemens Centaur

CPT Codes

CPT Modifier
(if needed)
Quantity Description Comments
82378        

Outreach CPT Codes

CPT Modifier
(if needed)
Quantity Description Comments
82378        

Ordering Applications

Ordering Application Description
Cerner CEA, Body Fluid